<html><body><h2>Case: 2185320</h2><h3> CDS Time: 1989-06-30</h3>
<patient name=2185320>
89.0 year old White_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">89</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">Calcium</td><td width="200">10</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">282</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">3</td><td width="200">1989-4-4</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">Height</td><td width="200">64</td><td width="200">1989-4-3</td></tr>
<tr><td width="200">Chloride</td><td width="200">103.0</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">62</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">BUN</td><td width="200">38</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">BNP</td><td width="200">4,052</td><td width="200">1989-4-3</td></tr>
<tr><td width="200">HGB</td><td width="200">12</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">HCT</td><td width="200">36</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">Sodium</td><td width="200">140</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">Albumen</td><td width="200">2</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.1</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">Weight</td><td width="200">190</td><td width="200">1989-4-3</td></tr>
<tr><td width="200">SGOT</td><td width="200">40</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">Pulse</td><td width="200">100</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">PLT</td><td width="200">351</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">WBC</td><td width="200">7</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">110</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">SGPT</td><td width="200">55</td><td width="200">1989-6-30</td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Cardiomegaly</td><td width="200"></td><td width="200">1989-4-3</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1989-4-6</td></tr>
<tr><td width="200">Myocardial_Infarction</td><td width="200"></td><td width="200">1989-4-3</td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Atrial_Fibrillation</td><td width="200"></td><td width="200">1989-4-5</td></tr>
</table>
<p><b>Medications:</b> triamterene(37.5) aspirin(162.0) betaxolol(2.0) lisinopril(2.5) hydrochlorothiazide(25.0) pravastatin(20.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of myocardial infarction]()</td></tr>
<tr><td width="200">Presence of K sparing diuretics</td>
<td width="200"></td>
<td width="200"> K sparing diuretics[presence of K sparing diuretics]()</td></tr>
<tr><td width="200">Heart Failure  (Secondary Prev) BP controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary Prevention)[Treatment_Diastolic_BP(62/null) && Treatment_Systolic_BP(110/null) && presence of heart failure]()</td></tr>
<tr><td width="200">MI (secondary prevention) BP controlled</td>
<td width="200"></td>
<td width="200"> Myocardial Infarction (Secondary Prevention)[Treatment_Diastolic_BP(62/null) && Treatment_Systolic_BP(110/null) && presence of myocardial infarction]()</td></tr>
<tr><td width="200">Heart Failure (second prev) BP cont</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary prevention)[Treatment_Diastolic_BP(62/null) && Treatment_Systolic_BP(110/null) && heart failure present]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(89.0/1970-1-1)]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(89.0/1970-1-1)]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Hypertension with MI and K>=3.5</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(3.9/1989-6-30) && presence of MI]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Hepatobiliary_Diseases</td>
<td width="200"></td>
<td width="200"> Active Liver Disease[SGPT(55.0/1989-6-30)]()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1989-04-03</td>
<td width="200"> Myocardial_Infarction()</td></tr>
<tr> <td width="200"></td>
<td width="200">1989-04-06</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1989-04-03</td>
<td width="200"> Cardiomegaly()</td></tr>
<tr> <td width="200"></td>
<td width="200">1989-04-05</td>
<td width="200"> Atrial_Fibrillation()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(3.9/1989-6-30) && presence of MI]()</td></tr>
<tr><td width="200">Hypertension_Defined</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(3.9/1989-6-30) && presence of MI]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 160 mg/dL(0-1 risk factors)
<p><b>Reached goal?</b> unknown(LDL_Cholesterol(no value))
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(62/null) && Treatment_Systolic_BP(110/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
<li>Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>aldosterone antagonist<ul><li>preference: neutral<li>No comment</ul><li>hydralazine and nitrates<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker for stage C heart failure(Carvedilol)<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker Stage C with MI(Carvedilol)<ul><li>preference: neutral<li>No comment</ul></ul><b>Considerations for adding drug: </b><ul><li>ARB<ul><li>preference: neutral<li>No comment</ul><li>digoxin<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker stage B post MI(Carvedilol)<ul><li>preference: neutral<li>No comment</ul><li>Ace_Inhibitor(Captopril, Lisinopril, Enalapril)<ul><li>Already being used<li><font color=FF0000>Compelling indications:  Myocardial_Infarction(Myocardial_Infarction) </font><li>preference: ruled out</ul><li>Beta Blocker Stage B no MI<ul><li>Already being used<li>preference: ruled out</ul><li>NDHP CCB<ul><li>Contraindications:  Heart_Failure(Cardiomegaly, Heart_Failure)  Myocardial_Infarction(Myocardial_Infarction) <li>preference: ruled out</ul></ul></body></html>